Advertisement

Topics

CheckMate Healthcare, Inc. Company Profile

01:35 EST 13th November 2018 | BioPortfolio

CheckMate Healthcare, Inc., is the industry’s first mobile app and platform that offers both at-home and in-lab STD testing while also including telemedicine treatment for the most common STD’s and revolutionary confidential results sharing capabilities among its users. The CheckMate app is available for free download in both the Apple or Google Play stores or by visiting www.checkmatehealthcare.com.


News Articles [343 Associated News Articles listed on BioPortfolio]

CheckMate Healthcare Announces Launch of Industry’s First Mobile STD Testing, Treatment, and Dating App Results Sharing Platform to Address Growing Epidemic

The CheckMate® App Allows for Private and Convenient At-Home Testing of STDs Aimed at Increasing the Testing Rates Nationwide Without the Need to Visit a Doctor’s ...

Borghaei Discusses Nivolumab/Ipilimumab CheckMate-227 NSCLC Findings

Hossein Borghaei, DO, MS, discusses the results of the subgroup analysis of the ongoing CheckMate-227 trial in metastatic non–small cell lung cancer.

Bristol-Myers Says Phase 3 CheckMate -331 Study Fails To Meet Primary Endpoint

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) today announced results from the Phase 3 CheckMate -331 study evaluating Opdivo or nivolumab versus the current standard of care, topot...

Bristol-Myers Squibb: FDA Action Removes Partial Hold On CheckMate -602

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co (BMY) announced that FDA lifted a partial clinical hold placed on CA209-602 (CheckMate -602), a randomized, open-label Phase 3 study evaluating th...

Bristol─Myers Squibb's phase 3 CheckMate─331 study does not meet primary endpont

Bristol─Myers Squibb Company announced topline results from the phase 3 CheckMate ─331 study evaluating Opdivo (nivolumab) versus the current standard of care, topotecan or amrubicin (where approv...

Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma

Dr Jonathan E. Rosenberg talks to ecancer at ESMO 2018 about the CHECKMATE-032 trial looking at nivolumab with ipilimumab for patients with metastatic urothelial carcinoma. After giving the latest da...

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Dr Ignacio Gil-Bazo speaks to ecancer at BEST OF ASCO® 2018 MIAMI SYMPOSIUM about the PROPHECY, PALOMA-3, CHECKMATE-227, and two further trials. He briefly outlines any new findings, data and result...

Bristol─Myers Squibb announces positive results from phase 3 CheckMate ─214 trial of Opdivo plus low─dose Yervoy in patients with advanced RCC

Bristol─Myers Squibb Company announced patient─reported outcomes data from the phase 3 CheckMate ─214 trial in intermediate─ and poor─risk patients with advanced renal cell carcinoma (RCC) t...

Drugs and Medications [446 Associated Drugs and Medications listed on BioPortfolio]

Bacti-stat [Ecolab Inc.]

Drug Facts

Oxygen [Mon HealthCare]

oxygen

Isagel [Coloplast Manufacturing US, LLC]

Isagel HandwashingNo-Rinse, Antiseptic Hand Cleansing Gel with Added Moisturizers

Endure 200 [Ecolab Inc.]

Drug Facts

Tiger balm [Haw Par Healthcare Ltd.]

TIGER BALM PAIN RELIEVING LARGE PATCH

PubMed Articles [1030 Associated PubMed Articles listed on BioPortfolio]

Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057.

Nivolumab, a programmed death-1 inhibitor, prolonged overall survival and had a favourable safety profile versus docetaxel in previously treated patients with advanced non-squamous non-small cell lung...

The Second Society for Simulation in Healthcare Research Summit: Beyond our Boundaries.

In this article, we report on the Second Society for Simulation in Healthcare Research Summit held in 2017. This meeting succeeded the First Research Summit from 2011 with the goal of advancing the sc...

Checkpoint Checkmate: Microbiota Modulation of Cancer Immunotherapy.

Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032.

For patients with recurrent small cell lung cancer (SCLC), topotecan remains the only FDA-approved or EMA-approved second-line treatment, and outcomes are poor. CheckMate 032 is a phase 1/2, multicent...

Stress Among Healthcare Professionals Calls Out for Attention.

Clinical Trials [1141 Associated Clinical Trials listed on BioPortfolio]

Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS)

Bone metastases are common in Non-Small Cell Lung Cancer (NSCLC). They most often occur during disease progression. It is thought that more than half of the patients with bone metastases w...

My Life, My Healthcare

This study is designed to answer the following questions: "Is the My Life, My Healthcare Discussion Aid feasible for use in primary care? Does it positively impact patient and healthcare t...

Asymptomatic Flu Project

Although clinical presentation of influenza is often symptomatic, asymptomatic cases also occur. The knowledge of the incidence of asymptomatic influenza among healthcare workers is very i...

Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care

Recently, we generated a new multidisciplinary ubiquitous healthcare system by upgrading our clinical decision supporting system (CDSS) rule engine, and integrating a physical activity-mon...

Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel

The purpose of the study on the Prevention of Influenza and Other Wintertime Respiratory Viruses among Healthcare Professionals in Israel Effectiveness of Influenza Vaccine in Preventing I...

Companies [1828 Associated Companies listed on BioPortfolio]

CheckMate Healthcare, Inc.

CheckMate Healthcare, Inc., is the industry’s first mobile app and platform that offers both at-home and in-lab STD testing while also including telemedicine treatment for th...

Checkmate Pharmaceuticals, Inc.

Checkmate Pharmaceuticals is a research and development company pursuing a novel approach to specifically activating the innate arm of the immune system to recognize and ultimatel...

Zelis™ Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

Zelis Healthcare

Zelis Healthcare is a healthcare information technology company and market-leading provider of end-to-end healthcare claims cost management and payments solutions including networ...

Sovereign Healthcare

Celebrating its 50th anniversary in 2012, Scottsdale Healthcare is the community-based, nonprofit parent organization of the Scottsdale Healthcare Osborn Medical Center, Scottsdal...

More Information about "CheckMate Healthcare, Inc." on BioPortfolio

We have published hundreds of CheckMate Healthcare, Inc. news stories on BioPortfolio along with dozens of CheckMate Healthcare, Inc. Clinical Trials and PubMed Articles about CheckMate Healthcare, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CheckMate Healthcare, Inc. Companies in our database. You can also find out about relevant CheckMate Healthcare, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record